Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese thr...
Saved in:
Published in | Orphanet journal of rare diseases Vol. 17; no. 1; pp. 1 - 16 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
02.09.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), [chl].sup.2 = 26.885, P < 0.001). This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. |
---|---|
AbstractList | Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature.BACKGROUNDHereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature.The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death.METHODSThe systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death.We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), χ2 = 26.885, P < 0.001).RESULTSWe described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), χ2 = 26.885, P < 0.001).This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years.CONCLUSIONSThis study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. Methods The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. Results We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), χ2 = 26.885, P < 0.001). Conclusions This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), [chl].sup.2 = 26.885, P < 0.001). This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. Abstract Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. Methods The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. Results We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), χ2 = 26.885, P < 0.001). Conclusions This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. Methods The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. Results We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), [chl].sup.2 = 26.885, P < 0.001). Conclusions This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years. Keywords: Transthyretin amyloidosis, Rare disease, Hereditary, Chinese |
ArticleNumber | 337 |
Audience | Academic |
Author | Zhang, Shuyang Guan, Hongzhi Tian, Zhuang He, Xinyue |
Author_xml | – sequence: 1 givenname: Xinyue surname: He fullname: He, Xinyue – sequence: 2 givenname: Zhuang orcidid: 0000-0003-1140-4062 surname: Tian fullname: Tian, Zhuang – sequence: 3 givenname: Hongzhi surname: Guan fullname: Guan, Hongzhi – sequence: 4 givenname: Shuyang surname: Zhang fullname: Zhang, Shuyang |
BookMark | eNp9kl1r2zAUhs3oWNtsf2BXht1sF-70ZUu6GZSwdoHCYB_XQpGPEwVHyiS5LP9-J03ZljKGETZHz3l93sN7WZ2FGKCqXlNyRanq3mfKCeMNYQyPULTRz6oLKlvSUCrZ2V_f59VlzhtCRMuJelGd8460neDsolrORx-8s2O9W0OIZb-DXNvQ1ysIULyrB7BlSliMQ72GBL0vNu3rkmzIZb1PCIXabvdj9H3MPtc7WzyEkmusz9c-2JfV88GOGV49vmfV95uP3-afmrvPt4v59V3jWilKMyhGmRAdlbRrW6I1EDL0rLUDZYRKIRRnUvG25z1zSi-p1IIT2WnROSWWms-qxVG3j3ZjdslvcVATrTcPhZhWxia0NIIRTjBriVrKHgThWjuiOqAg2dBphVuaVR-OWrtpuYXeoaFkxxPR05vg12YV7w3OpDihKPD2USDFHxPkYrY-OxhHGyBO2TBJtOTohyD65gm6iVMKuCqkaCsk-tZ_qJVFAz4MEf_rDqLmGjdGOMUcIHX1DwqfHrbeYXwGj_WThncnDcgU-FlWdsrZLL5-OWXZkXUp5pxg-L0PSswhkeaYSIOweUikOcytnjQ5TFDx8bA3P_6v9RfPAOIq |
CitedBy_id | crossref_primary_10_1016_j_hfc_2024_03_006 crossref_primary_10_1080_13506129_2024_2383467 crossref_primary_10_1016_S1634_7072_24_50005_8 crossref_primary_10_3390_jpm15020061 crossref_primary_10_1002_ana_27203 crossref_primary_10_3389_fneur_2024_1471131 |
Cites_doi | 10.1007/s00415-018-9125-z 10.1016/j.jocn.2018.10.040 10.1186/2046-4053-4-1 10.1097/MD.0000000000016566 10.1007/s12035-017-0694-0 10.1002/mus.26034 10.1097/MD.0000000000005737 10.3109/13506129.2014.892871 10.1038/srep26362 10.1080/13506129.2017.1292902 10.3109/13816810.2011.599356 10.1093/eurheartj/ehz173 10.1016/S1001-9294(09)60044-4 10.1016/j.jns.2011.02.005 10.1111/jns.12196 10.1136/jnnp-2014-308724 10.1016/j.exer.2013.02.005 10.1186/s13023-019-1000-1 10.1159/000321679 10.1038/eye.2013.217 10.1111/aos.13425 10.4103/0366-6999.168048 10.1038/eye.2014.10 10.1007/s00018-019-03357-1 10.1080/13506120802193720 10.1212/WNL.0b013e318248df18 10.1007/s11684-017-0516-9 10.1016/j.jacc.2016.03.596 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). The Author(s) 2022 |
Copyright_xml | – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). – notice: The Author(s) 2022 |
DBID | AAYXX CITATION ISR 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13023-022-02481-9 |
DatabaseName | CrossRef Gale In Context: Science ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1750-1172 |
EndPage | 16 |
ExternalDocumentID | oai_doaj_org_article_4c42aa08b7de40399c086e1e72f69845 PMC9438301 A716031022 10_1186_s13023_022_02481_9 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: ; – fundername: ; grantid: CIFMS 2021-I2M-1-003 |
GroupedDBID | --- 0R~ 123 29N 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BNQBC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ISR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW ~8M PMFND 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c574t-f8212446171655099e00fd25af12017448327835d3d2c89b17943076946c84b93 |
IEDL.DBID | M48 |
ISSN | 1750-1172 |
IngestDate | Wed Aug 27 01:28:30 EDT 2025 Thu Aug 21 18:45:49 EDT 2025 Thu Jul 10 18:20:36 EDT 2025 Fri Jul 25 07:35:21 EDT 2025 Tue Jun 17 21:49:17 EDT 2025 Tue Jun 10 20:48:48 EDT 2025 Fri Jun 27 04:25:35 EDT 2025 Thu Apr 24 23:16:23 EDT 2025 Tue Jul 01 02:23:31 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c574t-f8212446171655099e00fd25af12017448327835d3d2c89b17943076946c84b93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0003-1140-4062 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13023-022-02481-9 |
PMID | 36056432 |
PQID | 2715473279 |
PQPubID | 76088 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4c42aa08b7de40399c086e1e72f69845 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9438301 proquest_miscellaneous_2709737830 proquest_journals_2715473279 gale_infotracmisc_A716031022 gale_infotracacademiconefile_A716031022 gale_incontextgauss_ISR_A716031022 crossref_primary_10_1186_s13023_022_02481_9 crossref_citationtrail_10_1186_s13023_022_02481_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-02 |
PublicationDateYYYYMMDD | 2022-09-02 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-02 day: 02 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Orphanet journal of rare diseases |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | Y Sekijima (2481_CR1) 2015; 86 U Hellman (2481_CR39) 2008; 15 J Fan (2481_CR23) 2014; 42 J Xu (2481_CR33) 2017; 96 LC Meng (2481_CR2) 2015; 128 LA Jones (2481_CR42) 1991; 48 X Zou (2481_CR22) 2013; 110 T Yamashita (2481_CR5) 2012; 78 H Chen (2481_CR16) 2016; 6 BL Hu (2481_CR37) 2018; 35 H Guan (2481_CR19) 2015; 48 JY Liu (2481_CR17) 2011; 304 B Xie (2481_CR11) 2017; 95 K Fan (2481_CR24) 2019; 266 T Damy (2481_CR6) 2019; 43 Y Zhang (2481_CR35) 2011; 8 MW Cruz (2481_CR3) 2017; 24 J Xi (2481_CR30) 2010; 18 G Liu (2481_CR32) 2017; 22 M Waddington-Cruz (2481_CR41) 2019; 14 AM Zhang (2481_CR12) 2013; 19 YF Li (2481_CR13) 2008; 23 D Long (2481_CR21) 2012; 33 D Hu (2481_CR27) 2017; 11 J Yin (2481_CR9) 2014; 21 RB Ibrahim (2481_CR40) 2020; 77 MS Maurer (2481_CR38) 2016; 68 T Liu (2481_CR10) 2014; 28 K Fan (2481_CR25) 2019; 266 W Lv (2481_CR15) 2014; 28 LY Chen (2481_CR8) 2011; 4 Z Yuan (2481_CR29) 2019; 60 PW Zhu (2481_CR14) 2017; 35 D Moher (2481_CR7) 2015; 4 HH Schmidt (2481_CR4) 2018; 57 G Liu (2481_CR20) 2017; 22 Q Chen (2481_CR26) 2018; 55 J Qin (2481_CR28) 2019; 98 2481_CR34 2481_CR31 X Miao (2481_CR36) 2010; 17 MJ Xu (2481_CR18) 2007; 40 |
References_xml | – volume: 35 start-page: 555 issue: 06 year: 2018 ident: 2481_CR37 publication-title: J Apoplexy Nervous Dis – volume: 266 start-page: 232 issue: 1 year: 2019 ident: 2481_CR24 publication-title: J Neurol doi: 10.1007/s00415-018-9125-z – volume: 60 start-page: 164 year: 2019 ident: 2481_CR29 publication-title: J Clin Neurosci. doi: 10.1016/j.jocn.2018.10.040 – volume: 4 start-page: 1 year: 2015 ident: 2481_CR7 publication-title: Syst Rev doi: 10.1186/2046-4053-4-1 – volume: 98 issue: 30 year: 2019 ident: 2481_CR28 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000016566 – volume: 35 start-page: 181 issue: 03 year: 2017 ident: 2481_CR14 publication-title: Chin J Clin Lab Sci – volume: 55 start-page: 4911 issue: 6 year: 2018 ident: 2481_CR26 publication-title: Mol Neurobiol doi: 10.1007/s12035-017-0694-0 – volume: 57 start-page: 829 issue: 5 year: 2018 ident: 2481_CR4 publication-title: Muscle Nerve doi: 10.1002/mus.26034 – volume: 96 start-page: e5737 issue: 10 year: 2017 ident: 2481_CR33 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000005737 – volume: 21 start-page: 140 issue: 2 year: 2014 ident: 2481_CR9 publication-title: Amyloid doi: 10.3109/13506129.2014.892871 – volume: 6 start-page: 26362 year: 2016 ident: 2481_CR16 publication-title: Sci Rep doi: 10.1038/srep26362 – volume: 24 start-page: 109 issue: sup1 year: 2017 ident: 2481_CR3 publication-title: Amyloid doi: 10.1080/13506129.2017.1292902 – volume: 33 start-page: 28 issue: 1 year: 2012 ident: 2481_CR21 publication-title: Ophthalmic Genet doi: 10.3109/13816810.2011.599356 – volume: 43 start-page: 391 year: 2019 ident: 2481_CR6 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz173 – volume: 23 start-page: 230 issue: 4 year: 2008 ident: 2481_CR13 publication-title: Chin Med Sci J doi: 10.1016/S1001-9294(09)60044-4 – volume: 48 start-page: 7 issue: 01 year: 2015 ident: 2481_CR19 publication-title: Chin J Neurol – volume: 304 start-page: 83 issue: 1–2 year: 2011 ident: 2481_CR17 publication-title: J Neurol Sci doi: 10.1016/j.jns.2011.02.005 – ident: 2481_CR34 – volume: 22 start-page: 19 issue: 1 year: 2017 ident: 2481_CR20 publication-title: J Peripher Nervous Syst doi: 10.1111/jns.12196 – volume: 86 start-page: 1036 issue: 9 year: 2015 ident: 2481_CR1 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2014-308724 – volume: 22 start-page: 19 issue: 1 year: 2017 ident: 2481_CR32 publication-title: J Peripher Nerv Syst doi: 10.1111/jns.12196 – volume: 4 start-page: 329 issue: 3 year: 2011 ident: 2481_CR8 publication-title: Int J Ophthalmol – volume: 48 start-page: 979 issue: 5 year: 1991 ident: 2481_CR42 publication-title: Am J Hum Genet – volume: 40 start-page: 173 issue: 03 year: 2007 ident: 2481_CR18 publication-title: Chin J Neurol – volume: 110 start-page: 44 year: 2013 ident: 2481_CR22 publication-title: Exp Eye Res doi: 10.1016/j.exer.2013.02.005 – volume: 42 start-page: 784 issue: 9 year: 2014 ident: 2481_CR23 publication-title: Zhonghua Xin Xue Guan Bing Za Zhi – volume: 14 start-page: 34 issue: 1 year: 2019 ident: 2481_CR41 publication-title: Orphanet J Rare Dis doi: 10.1186/s13023-019-1000-1 – volume: 8 start-page: 187 issue: 4 year: 2011 ident: 2481_CR35 publication-title: Neurodegener Dis doi: 10.1159/000321679 – volume: 28 start-page: 26 issue: 1 year: 2014 ident: 2481_CR10 publication-title: Eye (Lond) doi: 10.1038/eye.2013.217 – volume: 95 start-page: e520 issue: 6 year: 2017 ident: 2481_CR11 publication-title: Acta Ophthalmol doi: 10.1111/aos.13425 – volume: 128 start-page: 2902 issue: 21 year: 2015 ident: 2481_CR2 publication-title: Chin Med J (Engl) doi: 10.4103/0366-6999.168048 – volume: 28 start-page: 452 issue: 4 year: 2014 ident: 2481_CR15 publication-title: Eye (Lond) doi: 10.1038/eye.2014.10 – volume: 17 start-page: 956 year: 2010 ident: 2481_CR36 publication-title: Chin J Integr Med Cardiocerebrovasc Dis – volume: 77 start-page: 1421 issue: 7 year: 2020 ident: 2481_CR40 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-019-03357-1 – volume: 266 start-page: 232 issue: 1 year: 2019 ident: 2481_CR25 publication-title: J Neurol doi: 10.1007/s00415-018-9125-z – volume: 18 start-page: 401 issue: 04 year: 2010 ident: 2481_CR30 publication-title: Chin J Clin Neurosci – volume: 15 start-page: 181 issue: 3 year: 2008 ident: 2481_CR39 publication-title: Amyloid doi: 10.1080/13506120802193720 – volume: 19 start-page: 1631 year: 2013 ident: 2481_CR12 publication-title: Mol Vis. – volume: 78 start-page: 637 issue: 9 year: 2012 ident: 2481_CR5 publication-title: Neurology doi: 10.1212/WNL.0b013e318248df18 – ident: 2481_CR31 – volume: 11 start-page: 293 issue: 2 year: 2017 ident: 2481_CR27 publication-title: Front Med doi: 10.1007/s11684-017-0516-9 – volume: 68 start-page: 161 issue: 2 year: 2016 ident: 2481_CR38 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.03.596 |
SSID | ssj0045308 |
Score | 2.3984413 |
Snippet | Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis.... Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor... Abstract Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1 |
SubjectTerms | Age Amyloidosis Autonomic nervous system Cardiomyopathy Chinese Death Family medical history Genotype & phenotype Genotypes Heart Hereditary Identification and classification Literature reviews Medical prognosis Medical research Mutation Patients Peripheral neuropathy Phenotype Phenotypes Rare disease Rare diseases Survival analysis Systematic review Transthyretin Transthyretin amyloidosis Vision |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDI_QDogL4lMUtikgJA6oWpqm-ThuE9NAGgdg0m5R2ibsSVuLlr4D__3sNO9pHRJcuDaO2thObDf2z4S816YVtRSs7LWqSwQkL01gvnQNOssmSOGxOPnsqzw9F18umos7rb4wJ2yGB54ZdyA6wZ1julW9FwzMaQdOuK-84kEaLRJ6Kdi8TTA1n8GiqZnelMhoeRDxeg7vK3mJGF5VaRZmKKH1_3km38-TvGN4Tp6Qx9ljpIfzlz4lD_zwjDw8y3fiz0mboT2vKKZrjfhPNVI39BRUAysUafAJvDPSMdBLbM25mtzNbzqhlQIxYRnjQN01RO6rfoyrSDPWaqTwPPXXfkHOTz79OD4tc-eEsmuUmMqgOdptiVg4EIIY4xkLPW9cqMDgKwjJauyw0fR1zzsQV4KJY0oaITstWlO_JDvDOPhXhLaIUW90qERbC4cOeQidb7XrtVRg_gtSbRhpuwwrjt0trmwKL7S0M_MtMN8m5ltTkI_bOb9mUI2_Uh-hfLaUCIidHoCa2Kwm9l9qUpB3KF2LkBcD5tT8dOsY7efv3-yhSq224Y0F-ZCJwghr6FwuUQBOIErWgnJ3QQl7slsOb5TI5jMhWq4qbPTMFazo7XYYZ2Ke2-DHNdIgfBKIhhVELZRvsfzlyLC6TLjgBmFnWfX6f_DrDXnE03YxsGN2yc50s_Z74H5N7X7aabf9fSjC priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4ilCCzIIiQOymjhObJ9QQVQFqRyASnuzHMduVypJWWcP_ffMeL0LAanXeKwk87Bn7JlvCHmjdCfqVpSsV7JmCEjOdCg9sw06yzq0wmNx8unX9uRMfFk0i3zgFnNa5XZNTAt1Pzo8Iz_kssI2uVzq91e_GHaNwtvV3ELjNrmD0GWo1XKxC7hEU5dqWyij2sOIl3R4a8kZInlVTM82o4TZ___K_G-25F_bz_EDcj_7jfRoI-iH5JYfHpG7p_lm_DHpMsDnJcWkrRFPViO1Q09BQbBOkQafIDwjHQO9wAady8murumEexUIC4sZB2p_Qvy-7Me4jDQjrkYKz1OX7Sfk7PjTj48nLPdPYK6RYmJBcdy9W0TEgUBEa1-WoeeNDRVs-xICsxr7bDR93XMHQktgcaVstWidEp2un5K9YRz8M0I7RKrXKlSiq4VFtzwE5ztle9VKcAIKUm0ZaVwGF8ceF5cmBRmqNRvmG2C-Scw3uiDvdnOuNtAaN1J_QPnsKBEWOz0YV-cmW5kRTnALn9fJ3osSfC8HEZuvvOQBvl40BXmN0jUIfDFgZs25XcdoPn__Zo5kargNbyzI20wURvgHZ3OhAnACsbJmlAczSrBMNx_eKpHJK0M0f_S4IK92wzgTs90GP66RBkGUQDRlQeRM-Wa_Px8ZlhcJHVwj-GxZPb_55fvkHk-GoMEWDsjetFr7F-BeTd3LZEO_AR98IOI priority: 102 providerName: ProQuest |
Title | Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China |
URI | https://www.proquest.com/docview/2715473279 https://www.proquest.com/docview/2709737830 https://pubmed.ncbi.nlm.nih.gov/PMC9438301 https://doaj.org/article/4c42aa08b7de40399c086e1e72f69845 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9NAEB_uA8QX8ROjZ1lF8EFW87HJZh9EenLHWeghdxb6tuRj965QE21S8P57Z7bbYvQQfCpkJ212Zqczk935_QBe56oUSSZCXucy4QRIzpUNDS9SSpaVzYSh5uTpeXY2E5N5Ot-DLd2RV2B3a2lHfFKz1fLdzx83H9HhPziHz7P3HW2-0W5kzAmhK-JqHw4xMkliNJiK3a6CSBPHUIcRM-QRDm-baG79jkGgcnj-f_9r_3mS8rfQdHof7vmcko03i-AB7JnmIdyZ-l3zR1B68M8lowNdLb117VjR1AwXD_UwMmscvGfHWsuuibxz0RerG9ZTHENDUqNjw4pvWNsv6rZbdMyjsXYMrzsG7scwOz35-umMe24FXqVS9NzmMUX2jNBysEhRyoShreO0sBGmBBKLtoQ4ONI6qeMKDeqA5EKZKZFVuShV8gQOmrYxT4GVhGKvchuJMhEFpezWVqbMizrPJJohgGirSF154HHiv1hqV4Dkmd4oX6PytVO-VgG83d3zfQO78U_pY7LPTpIgs92FdnWlvQdqUYm4wMcrZW1EiHlZhdWciYyMLT69SAN4RdbVBIrR0Kmbq2Lddfrz5YUeS0fGjb8YwBsvZFucQ1X4JgbUBOFoDSSPBpLotdVweLuI9HbR61hGRAUdS5zRy90w3Ukn4RrTrkmGAJbQNGEAcrD4BtMfjjSLa4ccrgiYNoye_Zd2n8Pd2PmFQtc4goN-tTYvMBPryxHsy7kcweF4PLmc4OfxyfmXi5F7rzFyrvcLL70ukA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXVF4iUMAgEAdkNXGcOD4gVB7VLu32AK20N5M4drvSkrSbrND-KX4jM95kISD11ms8UeLxjGfGnvmGkFeZKkScipCVmYwZApIz5ULL8gSdZeVSYbE4eXKcjk7Fl2ky3SK_-loYTKvs90S_UZe1wTPyPS4jbJPLpXp_ccmwaxTervYtNNZicWhXPyFka96NP8H6vub84PPJxxHrugowk0jRMpdxtGkp4sSAe66UDUNX8iR3ERhDCeFKjN0nkjIuuYGpeAg1iPaVSE0mCgRfgi3_BhjeEIM9Od0EeCKJw6wvzMnSvQYvBfGWlDNEDouYGhg_3yPgf0vwb3bmX-buYIfc6fxUur8WrLtky1b3yM1JdxN_nxQdoOicYpJYjSe5Dc2rkoJAYl0kddZDhja0dvQcG4LO2nyxoi3aRhAOLJ6saP5jNa9nZd3MGtohvDYUnvuu3g_I6bVw9iHZrurKPiK0QGR8lblIFLHIMQxwztgiy8ssleB0BCTqGalNB2aOPTXm2gc1WarXzNfAfO2Zr1VA3m7euVhDeVxJ_QHXZ0OJMNz-Qb04051Wa2EEz-H3CllaEYKvZyBCtJGV3MHfiyQgL3F1NQJtVJjJc5Yvm0aPv33V-9I3-IYvBuRNR-RqmIPJu8II4ARicw0odweUsBOY4XAvRLrbiRr9R28C8mIzjG9idl1l6yXSIGgTLE0YEDkQvsH0hyPV7NyjkSsEuw2jx1d__Dm5NTqZHOmj8fHhE3Kbe6VQoBe7ZLtdLO1TcO3a4pnXJ0q-X7cC_wYnMFkp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+phenotypes+and+genetic+features+of+hereditary+transthyretin+amyloidosis+patients+in+China&rft.jtitle=Orphanet+journal+of+rare+diseases&rft.au=He%2C+Xinyue&rft.au=Tian%2C+Zhuang&rft.au=Guan%2C+Hongzhi&rft.au=Zhang%2C+Shuyang&rft.date=2022-09-02&rft.issn=1750-1172&rft.eissn=1750-1172&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13023-022-02481-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13023_022_02481_9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1172&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1172&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1172&client=summon |